Search

ACD Pharma is constructing a large-scale phage production plant.

Bayside Solutions is seeking a Scientist II to be part of our client's team in the East Bay Area. This is an opportunity to work with the largest privately held pharmaceutical corporation in the world and ranks among the world's 20 leading

Janssen R&D LLC. is currently seeking to recruit a Microbiology Leader, Scientific Director, for a research and development team within the Infectious Diseases and Vaccines Therapeutic Area to be located in Spring House, PA. The Microbiolo

Janssen R&D LLC. is currently seeking to recruit a Microbiology Leader, Scientific Director, for a research and development team within the Infectious Diseases and Vaccines Therapeutic Area to be located in Spring House, PA. The Microbiolo

Bayside Solutions is seeking a Scientist II to be part of our client's team in the East Bay Area. This is an opportunity to work with the largest privately held pharmaceutical corporation in the world and ranks among the world's 20 leading

Intralytix announced that it will be collaborating with the Eliava Foundation and Ferring Pharmaceuticals to develop new phage-based drugs to improve reproductive medicine and women's health through modulation of the vaginal microbiome.

Intralytix announced that it will be collaborating with the Eliava Foundation and Ferring Pharmaceuticals to develop new phage-based drugs to improve reproductive medicine and women's health through modulation of the vaginal microbiome.

Bioharmony Therapeutics and Boehringer Ingelheim just announced a collaboration to develop Acinetobacter baumannii lysin therapeutics.

PharmExec.com has named phage therapy as one of the top 10 drug discovery trends to watch in 2019!

Bioharmony Therapeutics and Boehringer Ingelheim just announced a collaboration to develop Acinetobacter baumannii lysin therapeutics.

PharmExec.com has named phage therapy as one of the top 10 drug discovery trends to watch in 2019!

doing research related to phage therapy

CreatiPhage is committed to developing innovative phage-based medicines and personalized therapies to address the global threat of antimicrobial resistance.

Fagoterapia LAB s.r.l. is the first Italy-based start up developing antimicrobial therapy based on bacteriophages and their derivatives for treating antibiotic-resistant infections by using innovative tools of artificial intelligence for ei

"We are the only manufacturer of bacteriophages in Central Asia LLC ""AZIYA IMMUNOPREPARAT"". Today it produces medicinal products under the brand MediPhag 1) Bacteriophage staphylococcal liquid ""MediPhag"" Spray 20ml 2) Bacteriophage stap

Lxbio Pharmaceuticals is a Portuguese biotechnology company dedicated to developing innovative biopharmaceutical solutions, with a particular focus on phage therapy. Their mission is to revolutionize disease treatment and prevention, enhan

Micreos is a platform biotech company focused on discovering and developing recombinant proteins and phage-based antimicrobial vectors to target AMR pathogens in infectious diseases, dermatology, and oncology.

Lyon specialty pharma founded in 2025, developing phage therapies against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. Lyon FR

Democratize phage use - Starting in aquaculture

ScyTek Biotech Life Sciences manufactures diagnostic reagents, Special Stains, Antibodies, Hematology, Immunohistochemistry, buffers, Microbiology, Hematoxlyn etc https://www.scytek.com